Catherine Nyarady

March 09, 2021 | New York Law Journal

Last year, the Federal Circuit held that venue over Google was improper in the Eastern District of Texas where Google servers were used in non-Google-owned datacenters in the District but Google had no employees or agents there. In this edition of their Intellectual Property Litigation column, Eric Alan Stone and Catherine Nyarady report on 'Google' and certain subsequent cases where 'Google' was applied to determine whether venue was proper in cases involving infringement allegations against entities with corporate or contractual relationships in the relevant district.

By Eric Alan Stone and Catherine Nyarady

9 minute read

January 12, 2021 | New York Law Journal

In their Intellectual Property Litigation column, Eric Alan Stone and Catherine Nyarady report on several recent cases in New York federal courts that addressed the unsettled question of whether news organizations and other publishers infringe an author's rights by embedding social media posts containing copyrighted photographs.

By Eric Alan Stone and Catherine Nyarady

9 minute read

November 17, 2020 | New York Law Journal

The America Invents Act created the inter partes review proceeding and provided for the appointment of Administrative Patent Judges to preside over them. This term the Supreme Court will decide whether the Federal Circuit correctly held that the appointment of those judges was unconstitutional. In their Intellectual Property Litigation column, Eric Alan Stone and Catherine Nyarady write that the outcome could have a significant impact not only on inter partes reviews but on the power of administrative law judges in other agencies.

By Eric Alan Stone and Catherine Nyarady

9 minute read

February 01, 2007 | New York Law Journal

Catherine Nyarady, a partner at Paul, Weiss, Rifkind, Wharton & Garrison, writes that there is little doubt that MedImmune will create a flurry of increased declaratory judgment actions challenging patents - including between parties who had seemingly resolved their disputes. How such actions are framed (contract versus patent) and the specific language of the license agreement are clearly important. However, the long-term impact of the MedImmune decision remains to be seen.

By Catherine Nyarady

12 minute read